文献速递白血病

急性淋巴细胞白血病患儿巯嘌呤服药习惯、红细胞硫鸟嘌呤核苷酸水平与复发风险:儿童肿瘤学组AALL03N1研究

Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1.
PubMed 文献 · J Clin Oncol · 2017-03-24

该研究纳入441例TMPT野生型急性淋巴细胞白血病维持期患儿,用药物事件监测系统随访48,086患者日,评估6-巯嘌呤服药习惯与依从性、红细胞硫鸟嘌呤核苷酸水平及复发风险的关系。结果显示与乳制品同服和服药时间不固定与不依从相关,但调整依从性后服药习惯与复发风险及硫鸟嘌呤核苷酸水平无关。

要点

  • 43.8%患儿不依从,与乳制品同服(OR 1.9)和服药时间不固定(OR 3.4)与不依从相关。
  • 调整依从性后,6-巯嘌呤服药习惯与复发风险无显著关联。
  • 依从患儿中,服药习惯与红细胞硫鸟嘌呤核苷酸水平无显著关联。

核心结论

  • 常见6-巯嘌呤服药限制可能不影响结局,但可能妨碍依从性;未来建议应简化给药。

研究设计与样本

  • 儿童肿瘤学组AALL03N1研究,纳入441例TMPT野生型急性淋巴细胞白血病维持期口服6-巯嘌呤患儿,用药物事件监测系统随访48,086患者日。

主要发现

  • 中位年龄6岁(范围2至20岁),43.8%不依从(依从率<95%)。
  • 与乳制品同服(OR 1.9;95%CI 1.3至2.9;P=.003)和服药时间不固定(OR 3.4;95%CI 1.8至6.3;P=.0001)与不依从相关。
  • 调整依从性等后,与食物同服(HR 0.7;95%CI 0.3至1.9;P=.5)、与乳制品同服(HR 0.3;95%CI 0.07至1.5;P=.2)、晚间/夜间服药(HR 1.1;95%CI 0.2至7.8;P=.9)、时间不固定(HR 0.3;95%CI 0.04至2.7;P=.3)与复发风险无显著关联。
  • 依从患儿中,与食物同服vs不同服红细胞TGN水平206.1±107.1 vs 220.6±121.6(P=.5);与乳制品同服vs不同服220.1±87.8 vs 216.3±121.3(P=.7);晚间/夜间vs早晨/中午vs时间不固定218.8±119.7 vs 195.5±82.3 vs 174.8±93.4(P=.6),均无显著关联。

临床怎么用

  • 作者认为常见6-巯嘌呤服药限制可能不影响结局但可能妨碍依从性,未来建议应旨在简化给药。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Purpose Children with acute lymphoblastic leukemia (ALL) are generally instructed to take mercaptopurine (6-MP) in the evening and without food or dairy products. This study examines the association between 6-MP ingestion habits and 6-MP adherence, red cell thioguanine nucleotide (TGN) levels, and risk of relapse in children with TMPT wild-type genotype. Methods Participants included 441 children with ALL receiving oral 6-MP for maintenance. Adherence was monitored over 48,086 patient-days using the Medication Event Monitoring System; nonadherence was defined as adherence rate < 95%. 6-MP ingestion habits examined included: takes 6-MP with versus never with food, takes 6-MP with versus never with dairy, and takes 6-MP in the evening versus morning versus varying times. Results Median age at study was 6 years (range, 2 to 20 years); 43.8% were nonadherent. Certain 6-MP ingestion habits were associated with nonadherence (taking 6-MP with dairy [odds ratio (OR), 1.9; 95% CI, 1.3 to 2.9; P = .003] and at varying times [OR, 3.4; 95% CI, 1.8 to 6.3; P = .0001]). After adjusting for adherence and other prognosticators, there was no association between 6-MP ingestion habits and relapse risk (6-MP with food: hazard ratio [HR], 0.7; 95% CI, 0.3 to 1.9; P = .5; with dairy: HR, 0.3; 95% CI, 0.07 to 1.5; P = .2; taken in evening/night: HR, 1.1; 95% CI, 0.2 to 7.8; P = .9; at varying times: HR, 0.3; 95% CI, 0.04 to 2.7; P = .3). Among adherent patients, there was no association between red cell TGN levels and taking 6-MP with food versus without (206.1 ± 107.1 v 220.6 ± 121.6; P = .5), with dairy versus without (220.1 ± 87.8 v 216.3 ± 121.3; P =.7), or in the evening/night versus morning/midday versus varying times (218.8 ± 119.7 v 195.5 ± 82.3 v 174.8 ± 93.4; P = .6). Conclusion Commonly practiced restrictions surrounding 6-MP ingestion might not influence outcome but may hinder adherence. Future recommendations regarding 6-MP intake during maintenance therapy for childhood ALL should aim to simplify administration.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Landier W, Hageman L, Chen Y, et al. Mercaptopurine Ingestion Habits, Red Cell Thioguanine Nucleotide Levels, and Relapse Risk in Children With Acute Lymphoblastic Leukemia: A Report From the Children's Oncology Group Study AALL03N1. J Clin Oncol. 2017. PMID: 28339328. doi:10.1200/JCO.2016.71.7579

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。